ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 1942

$323K Total Retail Price of All Prescriptions

Rank: 413 out of 1942

380 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 9,141 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 472 437 1 2
LEVOTHYROXINE SODIUM 447 439 2 3
SIMVASTATIN 337 325 3 1
AMLODIPINE BESYLATE 311 286 4 6
OMEPRAZOLE 309 289 5 4
METOPROLOL SUCCINATE 244 231 6 13
METOPROLOL TARTRATE 242 228 7 9
FUROSEMIDE 214 214 8 5
POLYETHYLENE GLYCOL 3350 197 197 9 28
WARFARIN SODIUM 192 192 10 11
METFORMIN HCL 179 141 11 10
HYDROCODONE-ACETAMINOPHEN 173 143 S3 12 12
SPIRONOLACTONE 171 170 13 59
GABAPENTIN 163 152 14 16
ATENOLOL 160 160 15 7
CITALOPRAM HBR 160 159 15 15
LOSARTAN POTASSIUM 155 147 17 18
SERTRALINE HCL 149 148 18 20
POTASSIUM CHLORIDE 139 132 19 17
PREDNISONE 133 132 20 27
TAMSULOSIN HCL 130 128 21 29
DONEPEZIL HCL 128 116 22 30
CARVEDILOL 124 116 23 39
FENTANYL 124 123 S2 23 47
PRAVASTATIN SODIUM 119 98 25 23
ALLOPURINOL 107 103 26 26
HYDROCHLOROTHIAZIDE 100 100 27 8
NAMENDA 99 99 28 51
FINASTERIDE 96 94 29 86
TRAMADOL HCL 96 84 29 19
ALENDRONATE SODIUM 90 78 31 21
RANITIDINE HCL 87 86 32 31
TERAZOSIN HCL 84 71 33 77
DIGOXIN 84 84 33 40
ISOSORBIDE MONONITRATE ER 82 82 35 42
HYDRALAZINE HCL 78 78 36 108
CLOPIDOGREL 75 75 37 55
TRIAMTERENE-HCTZ 75 62 37 36
ATORVASTATIN CALCIUM 74 74 39 14
OXYCONTIN 72 72 S2 40 84
DOXAZOSIN MESYLATE 66 66 41 72
TRAZODONE HCL 64 43 42 24
FAMOTIDINE 61 50 43 87
METFORMIN HCL ER 61 44 43 46
VENLAFAXINE HCL ER 60 57 45 70
GLIMEPIRIDE 56 36 46 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 56 46 22
PLAVIX 56 56 46 83
CARBIDOPA-LEVODOPA 53 50 49 64
MIRTAZAPINE 52 48 50 38
PAROXETINE HCL 51 32 51 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.